Szerző: admin | nov 15, 2022 | Blog
Blood-derived biomarkers in prostate cancer Prostate cancer (PCa) is the second most commonly occurring cancer in men, accounting for 14.1% of all male cases, and the fourth most common cancer overall (Sung et al., 2021). There were more than 1.4 million new cases of...
Szerző: admin | okt 24, 2022 | Blog
Clonal evolution monitoring in cancer with liquid biopsy In the last part of our blog series, we will focus on the process by which subclones in tumors change over time and how liquid biopsy can be applied in monitoring clonal evolution and heterogeneity in tumors....
Szerző: admin | szept 28, 2022 | Blog
The role of liquid biopsy in precision medicine In the third part of our blog series, we will discuss how liquid biopsy have revolutionized the field of precision medicine and opened up new ways in cancer management. Precision medicine in oncology aims to understand...
Szerző: admin | aug 16, 2022 | Blog
Refining Cancer Treatment Monitoring Using Liquid Biopsy Liquid biopsy has broad application possibilities in cancer diagnosis and patient monitoring, covering involvement in early diagnosis, prognosis as well as monitoring of therapeutic response. In the second part...
Szerző: admin | júl 13, 2022 | Blog
Tracking Minimal Residual Disease with Liquid Biopsy In the first piece of our four-part blog series–exploring the application possibilities of liquid biopsy–, we will discuss the current horizon and future perspective of liquid biopsy-based minimal residual disease...
